Functional E3 ligase hotspots and resistance mechanisms to small-molecule degraders

被引:54
|
作者
Hanzl, Alexander [1 ]
Casement, Ryan [2 ]
Imrichova, Hana [1 ]
Hughes, Scott J. [2 ,3 ]
Barone, Eleonora [1 ]
Testa, Andrea [2 ,3 ]
Bauer, Sophie [1 ,4 ]
Wright, Jane [2 ]
Brand, Matthias [1 ,4 ]
Ciulli, Alessio [2 ]
Winter, Georg E. [1 ]
机构
[1] Austrian Acad Sci, CeMM Res Ctr Mol Med, Vienna, Austria
[2] Univ Dundee, James Black Ctr, Sch Life Sci, Div Biol Chem & Drug Discovery, Dundee, Scotland
[3] Amphista Therapeut Ltd, Newhouse, Scotland
[4] Proxygen GmbH, Vienna, Austria
基金
欧洲研究理事会; 奥地利科学基金会; 英国惠康基金; 英国生物技术与生命科学研究理事会;
关键词
TARGETED PROTEIN-DEGRADATION; UBIQUITIN LIGASE; STRUCTURAL BASIS; IDENTIFICATION; OPTIMIZATION; INHIBITORS; TOOLKIT; DESIGN;
D O I
10.1038/s41589-022-01177-2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Targeted protein degradation is a novel pharmacology established by drugs that recruit target proteins to E3 ubiquitin ligases. Based on the structure of the degrader and the target, different E3 interfaces are critically involved, thus forming defined 'functional hotspots'. Understanding disruptive mutations in functional hotspots informs on the architecture of the assembly, and highlights residues susceptible to acquire resistance phenotypes. Here we employ haploid genetics to show that hotspot mutations cluster in substrate receptors of hijacked ligases, where mutation type and frequency correlate with gene essentiality. Intersection with deep mutational scanning revealed hotspots that are conserved or specific for chemically distinct degraders and targets. Biophysical and structural validation suggests that hotspot mutations frequently converge on altered ternary complex assembly. Moreover, we validated hotspots mutated in patients that relapse from degrader treatment. In sum, we present a fast and widely accessible methodology to characterize small-molecule degraders and associated resistance mechanisms.
引用
收藏
页码:323 / +
页数:26
相关论文
共 50 条
  • [1] Functional E3 ligase hotspots and resistance mechanisms to small-molecule degraders
    Alexander Hanzl
    Ryan Casement
    Hana Imrichova
    Scott J. Hughes
    Eleonora Barone
    Andrea Testa
    Sophie Bauer
    Jane Wright
    Matthias Brand
    Alessio Ciulli
    Georg E. Winter
    Nature Chemical Biology, 2023, 19 : 323 - 333
  • [2] Discovery of small-molecule positive allosteric modulators of Parkin E3 ligase
    Shlevkov, Evgeny
    Murugan, Paramasivam
    Montagna, Dan
    Stefan, Eric
    Hadzipasic, Adelajda
    Harvey, James S.
    Kumar, P. Rajesh
    Entova, Sonya
    Bansal, Nupur
    Bickford, Shari
    Wong, Lai-Yee
    Hirst, Warren D.
    Weihofen, Andreas
    Silvian, Laura F.
    ISCIENCE, 2022, 25 (01)
  • [3] Small-Molecule Targeting of E3 Ligase Adaptor SPOP in Kidney Cancer
    Guo, Zhong-Qiang
    Zheng, Tong
    Chen, Baoen
    Luo, Cheng
    Ouyang, Sisheng
    Gong, Shouzhe
    Li, Jiafei
    Mao, Liu-Liang
    Lian, Fulin
    Yang, Yong
    Huang, Yue
    Li, Li
    Lu, Jing
    Zhang, Bidong
    Zhou, Luming
    Ding, Hong
    Gao, Zhiwei
    Zhou, Liqun
    Li, Guoqiang
    Zhou, Ran
    Chen, Ke
    Liu, Jingqiu
    Wen, Yi
    Gong, Likun
    Ke, Yuwen
    Yang, Shang-Dong
    Qiu, Xiao-Bo
    Zhang, Naixia
    Ren, Jin
    Zhong, Dafang
    Yang, Cai-Guang
    Liu, Jiang
    Jiang, Hualiang
    CANCER CELL, 2016, 30 (03) : 474 - 484
  • [4] Re: Small-Molecule Targeting of E3 Ligase Adaptor SPOP in Kidney Cancer
    Atala, Anthony
    JOURNAL OF UROLOGY, 2018, 199 (03): : 612 - 612
  • [5] Small-Molecule Inhibitors of the Interaction between the E3 Ligase VHL and HIF1a
    Buckley, Dennis L.
    Gustafson, Jeffrey L.
    Van Molle, Inge
    Roth, Anke G.
    Tae, Hyun Seop
    Gareiss, Peter C.
    Jorgensen, William L.
    Ciulli, Alessio
    Crews, Craig M.
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2012, 51 (46) : 11463 - 11467
  • [6] Targeting TRAF6 E3 ligase activity with a small-molecule inhibitor combats autoimmunity
    Brenke, Jara K.
    Popowicz, Grzegorz M.
    Schorpp, Kenji
    Rothenaigner, Ina
    Roesner, Manfred
    Meininger, Isabel
    Kalinski, Cedric
    Ringelstetter, Larissa
    R'kyek, Omar
    Juerjens, Gerrit
    Vincendeau, Michelle
    Plettenburg, Oliver
    Sattler, Michael
    Krappmann, Daniel
    Hadian, Kamyar
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2018, 293 (34) : 13191 - 13203
  • [7] Discovery of small molecule ligands for the von Hippel-Lindau (VHL) E3 ligase and their use as inhibitors and PROTAC degraders
    Diehl, Claudia J.
    Ciulli, Alessio
    CHEMICAL SOCIETY REVIEWS, 2022, 51 (19) : 8216 - 8257
  • [8] Design and synthesis of putative small-molecule inhibitors targeting the SCFSKP2 E3 ligase complex
    Shouksmith, Andrew E.
    Evans, Laura E.
    Griffin, Roger J.
    Golding, Bernard T.
    Newell, Herbie
    Miller, Duncan C.
    Noble, Martin E. M.
    Endicott, Jane A.
    Tweddle, Deborah
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 247
  • [9] A strategy for small-molecule RNA degraders
    Alex Eccleston
    Nature Reviews Drug Discovery, 2023, 22 : 621 - 621
  • [10] A strategy for small-molecule RNA degraders
    Eccleston, Alex
    NATURE REVIEWS DRUG DISCOVERY, 2023, 22 (08) : 621 - 621